The rate of incidents of drug violations in Canada decreased by 23.5 incidents (-17.15 percent) in 2023 in comparison to the previous year. In 2023, the rate of incidents thereby reached its lowest value in the recent years.

This statistic shows the total number of drug-related offenses in Canada from 2000 to 2023. There were 45,530 drug-related offenses nationwide in Canada in 2023. Drug-related CrimeDrug-related crime is any crime that has to do with the manufacture, sale, possession, or transportation of a substance illegal under Canada’s criminal code. Drug-related crime is one of the few areas of crime in Canada that has been on the decline over the last few decades. From 2000 to 2023 the rate of drug-related offenses in Canada has decreased. Before 2018, by far, the largest portion of drug-related offenses in Canada was for the possession of cannabis. The number of all offenses related to cannabis was over four times higher than the next illicit substance. Likewise, possession of any substance was also the most common drug-related offense, occurring almost four times as frequently as the next offense. The vast majority of youths who were found guilty of a drug-related offense in criminal courts are sentenced to probation. In contrast, adults were dealt with more strictly, with the distribution of sentences for the guilty being even between, probation, fines, and custody.

These data are part of NACJD's Fast Track Release and are distributed as they were received from the data depositor. The files have been zipped by NACJD for release, but not checked or processed except for the removal of direct identifiers. Users should refer to the accompanying readme file for a brief description of the files available with this collection and consult the investigator(s) if further information is needed. In this study, researchers used capture-recapture sampling and multiple data sources to gauge the impact of drug trafficking in Quebec, Canada on the United States drug market. The main analyses were based on arrest data that were obtained for Quebec. In addition, analysis of the chemical composition and price assessments of the Quebec synthetic drugs was done. The study includes one SPSS data file (Quebec Arrest Data (Synthetic Drugs Cases, September 2014; n=20261)-ICPSR.sav ; n=20,261 ; 13 variables) and one Excel data file (Chemical composition of seized synthetic drugs.xls ; n=365 ; 14 variables). Spatial analyses of border seizure data was performed by the researchers, but these data are not available at this time. The data used for these analyses concerned synthetic drug seizures at Canadian borders from 2007 to 2012. The dataset was provided by the Canadian Border Services Agency (CBSA). For each seizure, the specific border crossing where the seizure was made was provided, as well as the value of the seizure (except for precursors), the country of origin and the type of drug seized. The types of drugs were classified into five types: (1) Precursors, (2) MDMA, (3) Amphetamine, (4) Methamphetamine and (5) Others. Most of the seizures (86.6 percent) were classified in this last category. The country of origin of the seizure was also provided.

This statistic shows the percentage of adults found guilty of drug related offences in Canada from 2008 to 2012, by type of drug. Forty-four percent of adults who were prosecuted for cannabis-related offences were found guilty in Canada from 2008 to 2012.

This statistic shows the number of cases filed against youths for drug related offences in Canada from 2008 to 2012, by type of drug. There were 1,994 cases filed against youths for cocaine-related offences in Canada from 2008 to 2012.

This fact sheet presents information on criminal court cases where the most serious offence in the case is a drug-related offence subject to a mandatory minimum penalty (MMP). Data were obtained through a request to the Canadian Centre for Justice and Community Safety Statistics (CCJCSS) and cover the period from 2014/2015 to 2019/2020.

Police-reported organized crime, by most serious violation (homicide and attempted murder, assault, sexual violations, kidnapping and hostage taking, human trafficking, robbery and theft, firearm and weapons violations, extortion and criminal harassment, arson, forgery and fraud, child pornography, criminal organization involvement, probation and court violations, drug possession and trafficking, and other violations), Canada (selected police services), 2016 to 2023.

This statistic shows the number of drug related offenses in Canada in 2023, by territory or province. There were 11,314 drug-related offenses in Quebec, Canada in 2023.

The objective of the Adult Criminal Court Survey (ACCS) is to develop and maintain a database of statistical information on appearances, charges, and cases in adult criminal courts. The survey is intended to be a census of federal statute charges heard in provincial and superior criminal courts in Canada. It includes information on the age and sex of the accused, case decision patterns, sentencing information regarding the length of prison and probation, and amount of fine, as well as case-processing data such as case elapsed time. These data on federal statute charges heard in adult criminal courts in the reference period are collected by the Canadian Centre for Justice Statistics (CCJS) in collaboration with provincial and territorial government departments responsible for adult criminal courts. The data are collected to respond to the needs of the provincial/territorial and federal departments of justice and attorneys-general, researchers and policy analysts, academics and the media, as well as to inform the public how adults are dealt with by adult provincial/territorial criminal courts in Canada. The ACCS has been replaced by the Integrated Criminal Court Survey (ICCS).

This statistic shows the number of drug-related offenses in Canada in 2022, by metropolitan area. There were 5,942 drug-related offenses in the Vancouver area in Canada in 2023.

Adult criminal courts, charges and cases by offence, age and sex of accused and type of decision, Canada, provinces, territories, ten jurisdictions and eight jurisdictions, five years of data.

The Canadian Clinical Drug Dataset is a drug terminology and coding system designed to allow the interchange of standardized drug and medical device information between diverse digital health systems. Some use cases include electronic prescribing, electronic medical records, medication reconciliation and analytics. It also provides for the classification and identification of defined groups of medications (called special groupings), such as narcotic and controlled drugs. It has the capacity to be used by knowledge-based vendors, clinicians, researchers, statistical users, government agencies, healthcare organisations and consumers. The data source for the CCDD is the Drug Product Database (DPD) which contains information on drugs approved by Health Canada. However, the data is modeled differently following the CCDD Editorial Guidelines which take into consideration international terminology standards. For example, DPD uses the dosage form, “tablet (delayed-release)”, whereas CCDD uses the equivalent term “gastro-resistant tablet.” The Canadian Clinical Drug Data Set does not replace the Health Canada Drug Product Database (DPD) but is published in addition to it. The scope of health products included in CCDD is limited to those classified as human in DPD (veterinary, radiopharmaceutical and disinfectant products are out of scope). Some exclusions apply within the human class but are subject to periodic review: For a full list of exclusions, please see the Scope section in the CCDD Editorial Guidelines. In addition, a limited number of medical devices that are commonly prescribed and dispensed at a community pharmacy are included. This data set was developed in collaboration with Canada Health Infoway and is also available in their Terminology Gateway at https://tgateway.infoway-inforoute.ca/ccdd.html (Free login required)

This statistic shows the total number of drug-trafficking, production, or distribution offenses in Canada from 2000 to 2023. There were 20,203 drug trafficking, production, or distribution offenses nationwide in Canada in 2023.

Forecast: Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases in Canada 2024 - 2028 Discover more data with ReportLinker!

Snapshot img

Phenylketonuria Treatment Market Size 2024-2028

The phenylketonuria treatment market size is forecast to increase by USD 339.6 million at a CAGR of 6.7% between 2023 and 2028.

Phenylketonuria (PKU), a genetic disorder affecting amino acid metabolism, necessitates careful management to prevent complications. Treatment approaches include dietary management and drug therapy. Dietary management involves strict adherence to a low-protein diet to limit phenylalanine intake. Drug therapy includes oral and parenteral administration of phenylalanine-lowering agents. Market trends include increasing investments in genomic research and development, driving advancements in PKU treatment. Strategic alliances among market players further boost innovation. However, the high cost of treatment remains a significant challenge, limiting access for many patients. This report provides a comprehensive analysis of the treatment market, covering adult and pediatric medical devices management, and the role of hospitals and specialty clinics in its delivery.

What will the Phenylketonuria Treatment Market Size during the forecast period?

Request Free Sample

Phenylketonuria (PKU), a metabolic disorder characterized by the inability to metabolize phenylalanine (Phe), necessitates stringent management for optimal patient outcomes. Early diagnosis through newborn screening programs and subsequent implementation of appropriate therapies play a crucial role in mitigating the adverse effects of this condition. Currently, the primary treatment for PKU involves adhering to a low-Phe diet and, in some cases, pharmacological interventions. The low-Phe diet restricts the intake of Phe-rich foods to prevent the accumulation of toxic levels in the blood.



This dietary management is essential for managing PKU, as elevated Phe levels can lead to neurocognitive impairments and other complications. Pharmacological interventions, such as sapropterin dihydrochloride, are employed to enhance metabolic control in individuals with PKU. These treatments aim to reduce the body's production of Phe or enhance its metabolism, thereby improving patient outcomes. Genetic testing is another crucial aspect of PKU management. Identifying carriers and at-risk individuals through genetic testing can help prevent the condition's transmission and facilitate early intervention. Hospitals and clinics play a vital role in providing genetic testing services and managing PKU patients through teleconsultancy and regular monitoring.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Drug Class

  Sapropterin
  Pegvaliase-pqpz


Geography

  North America

    Canada
    US


  Europe



  Asia



  Rest of World (ROW)

By Drug Class Insights

The sapropterin segment is estimated to witness significant growth during the forecast period.

Phenylketonuria (PKU), a genetic disorder affecting amino acid metabolism, requires careful management to prevent the buildup of phenylalanine in the blood. Two primary approaches for PKU treatment are dietary management and drug therapy. Sapropterin dihydrochloride, a synthetic formulation of the active 6R-isomer of tetrahydrobiopterin, is an approved treatment for tetrahydrobiopterin-responsive PKU in Europe for patients over 4 years old and in adults and children responsive to such treatment. In the market, sapropterin is authorized to reduce blood phenylalanine levels in patients with tetrahydrobiopterin-responsive PKU. This medication is administered orally and has been proven effective in lowering blood phenylalanine levels in randomized, double-blind trials.

Furthermore, hospitals, healthcare services, and specialty clinics are common settings for PKU treatment, offering both dietary management and drug therapy options. Hence, such factors are fuelling the growth of this segment during the forecast period.

Get a glance at the market report of share of various segments Request Free Sample

The sapropterin segment was valued at USD 443.10 million in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 33% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions Request Free Sample

The prevalence of Phenylketonuria (PKU), a genetic disorder affecting amino acid metabolism, is on the rise in the United States, leading to a growing need for effective treatment solutions. Newborn screening programs have become increasingly

The dataset includes incident-based crime statistics at the provincial and police service level. Statistics include the number of incidents of offences and rates per 100,000 population for the following offences: Homicide, Attempted murder , Sexual assault (Levels 1, 2 and 3), Total sexual violations against children, Assault (Levels 1, 2 and 3), Total robbery, Total breaking and entering, Total theft of motor vehicle, Total impaired driving, Total drug violations, Possession (cannabis), Possession, (cocaine), Possession (other Controlled Drugs and Substances Act drugs), Cannabis (trafficking, production or distribution), Cocaine (trafficking, production or distribution), Other Controlled Drugs and Substances Act drugs (trafficking, production or distribution). Data source: Statistics Canada.

Incident-based crime statistics (actual incidents, rate per 100,000 population, percentage change in rate, unfounded incidents, percent unfounded, total cleared, cleared by charge, cleared otherwise, persons charged, adults charged, youth charged / not charged), by detailed violations (violent, property, traffic, drugs, other Federal Statutes), Canada, provinces, territories, Census Metropolitan Areas and Canadian Forces Military Police, 1998 to 2023.

Abbreviations: No., number; vs, versus; MDR multidrug-resistant; OR odds ratio; CBA Canadian-born Aboriginal; CBO Canadian-born ‘other’; FB foreign-born; HIV human immunodeficiency virus.*Refers to resistance to one or more first-line drugs but not meeting the definition of MDR.†Confidence Intervals calculated using Fisher’s exact methods; ORs reaching statistical significance, based on non-overlapping 95% CIs are highlighted in italics.‡As defined by the Canadian Tuberculosis Standards (1).§includes primary, respiratory, and ‘other respiratory’.IIincludes peripheral lymph nodes, miliary, CNS and other non-respiratory.

Before drugs can be sold to Canadians, they must meet high safety and quality standards. This is the case for drugs made in Canada or abroad. Learn about drug inspections, how the Government of Canada (GC) conducts them and our licensing practices.

The objective of the Adult Criminal Court Survey (ACCS) is to develop and maintain a database of statistical information on appearances, charges, and cases in adult criminal courts. The survey is intended to be a census of federal statute charges heard in provincial and superior criminal courts in Canada. It includes information on the age and sex of the accused, case decision patterns, sentencing information regarding the length of prison and probation, and amount of fine, as well as case-processing data such as case elapsed time. These data on federal statute charges heard in adult criminal courts in the reference period are collected by the Canadian Centre for Justice Statistics (CCJS) in collaboration with provincial and territorial government departments responsible for adult criminal courts. The data are collected to respond to the needs of the provincial/territorial and federal departments of justice and attorneys-general, researchers and policy analysts, academics and the media, as well as to inform the public how adults are dealt with by adult provincial/territorial criminal courts in Canada. For current ACCS data refer to Statistics Canada The ACCS has been replaced by the Integrated Criminal Court Survey (ICCS) Access data here